0001209191-17-043695.txt : 20170705 0001209191-17-043695.hdr.sgml : 20170705 20170705184100 ACCESSION NUMBER: 0001209191-17-043695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170703 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2065821600 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harr Steve CENTRAL INDEX KEY: 0001627387 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36781 FILM NUMBER: 17950132 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVE. NORTH, STE. 300 CITY: SEATTLE STATE: WA ZIP: 98109 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-03 0 0001594864 Juno Therapeutics, Inc. JUNO 0001627387 Harr Steve C/O 307 WESTLAKE AVENUE N STE 300 SEATTLE WA 98109 0 1 0 0 CFO & Head, Corp. Development Common Stock 2017-07-03 4 M 0 8750 8.72 A 736189 D Common Stock 2017-07-03 4 S 0 8750 30.00 D 727439 D Stock Option (Right to Buy) 8.72 2017-07-03 4 M 0 8750 0.00 D 2024-11-13 Common Stock 8750 107500 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2014, as amended March 24, 2015. 1/48th of the shares subject to the option vested and became exercisable on December 14, 2014 and 1/48th of the shares subject to the option shall vest monthly thereafter. /s/ Zachary D. Hale, attorney-in-fact 2017-07-05